CareDx’s Second Act with CEO John Hanna
CareDx, under CEO John Hanna, is evolving into a clinical ecosystem for transplantation, integrating molecular diagnostics like AlloSure with software and services. Hanna emphasizes a "solution selling" approach to replace invasive biopsies with scalable, blood-based monitoring…